PARP Inhibitors Can Be Effective as Part of Initial Treatment for Ovarian Cancer

Fact Checked

SurvivorNet Fact Checking and Medical Review Standards:  

The SurvivorNet News Team creates high quality medical information that complies with our industry leading standards for factual accuracy and sourcing from leading experts at academic medical institutions. Every news article is thoroughly fact-checked by our physician collaborators. We vet each piece of work for factual integrity, impartiality, and clearly label any professional conflicts.

All SurvivorNet articles adhere to the following standards:

  1. All studies and research papers cited are from reputable academic medical institutions or peer-reviewed journals.
  2. When we use data, statistics, or quotes these references link to the original source.
  3. All content related to new treatments, drugs, procedures, and so on must clearly describe availability, side effects, treatment target (such as triple negative breast cancer)
  4. All medical information on SurvivorNet is sourced from respected medical professionals with verified medical credentials and links are provided to these sources.
  5. We strive to give the reader relevant background information and include, clearly-sourced contextual health information in all articles. Readers are clearly alerted to any conflicts of interest from a medical source or the authors of a cited study.
/ Updated August 17th, 2021

PARP Inhibitors Can Be Effective as Part of Initial Treatment for Ovarian Cancer

NOW
PLAYING
PARP Inhibitors: Why is Genetic Testing Important?
NOW
PLAYING
PARP Inhibitors for Ovarian Cancer: An Overview
NOW
PLAYING
What's the Best Initial Treatment for Your Ovarian Cancer? That Depends
NOW
PLAYING
Making Treatment Decisions after an Ovarian Cancer Cancer Diagnosis
NOW
PLAYING
Ovarian Cancer: The Robotic Surgery Experience
NOW
PLAYING
How Do I Choose an Ovarian Cancer Surgeon?
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.